• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

Heparin

(CAS: 9005-49-6)
9 Quality Control and Spectral Data: 0 Solubility Information: 1 Storage Condition Information: 0 MSDS Information: 0 Related Products: Other Forms of Heparin: 2 Recommended Products in the Same Target: 626 Recommended Products in the Same Indication: 180 Clinical and Indication Information: Phase 4 (Stable Angina|Angina, Unstable|Non-ST Elevation (NSTEMI) Myocardial Infarction) (Obesity|Morbid Obesity|Venous Thromboembolism|Atrial Fibrillation|Angina|Chest Pain) Phase 3 (Recurrent Pregnancy Loss) Phase 3 (Postoperative Hemorrhage) (Venous Thromboembolism) Phase 4 (Renal Failure) Phase 4 (Arteriovenous Fistula) Phase 4 (Aortic Stenosis, Non-rheumatic) Phase 2|Phase 3 (Chronic Renal Failure) Phase 3 (Sepsis|Disseminated Intravascular Coagulation) Phase 3 (Cardiac Surgery) Phase 2 (Aneurysmal Subarachnoid Hemorrhage|Neurobehavioral Manifestations|Vasospasm, Intracranial|Intracranial Aneurysm|Heparin-induced Thrombocytopenia Type II) (Renal Failure Chronic Requiring Hemodialysis) Phase 3 (Prevention of Venous Thromboembolism) Phase 2 (Cardiogenic Shock) Phase 3 (Coagulation; Intravascular) Phase 4 (Coronary Angiography) (Thrombosis) Phase 4 (Catheter-Related Infections) Phase 4 (ST-segment Elevation Myocardial Infarction|Non ST-segment Elevation Myocardial Infarction) Phase 4 (Coronary Angiograph) Phase 2|Phase 3 (Deep Venous Thrombosis) Phase 4 (Coronary Artery Disease) Phase 4 (Pregnancy|Thrombophilia) Phase 3 (To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come) (Infant, Premature|Anticoagulants|Thrombosis) Phase 3 (Thrombus) (Cancer) Phase 4 (Catheter Related Infection) Phase 2 (Embolic Stroke) Early Phase 1 (Deep-Venous Thrombosis|Pulmonary Embolism|Venous Thromboembolism) (Lower Extremity Deep Venous Thrombosis) Phase 3 (Severe Sepsis With Septic Shock|Severe Sepsis Without Septic Shock) Phase 3 (Hip Fracture Surgery) Phase 3 (End Stage Renal Disease) Phase 4 (Acute Ischemic Stroke) Phase 4 (Cardiac Surgery|Extracorporeal Circulation) (Venous Thrombosis) (End Stage Renal Failure on Dialysis) Phase 4 (Catheter-related Bloodstream Infection (CRBSI) Nos) (Chronic Kidney Disease|Patients Requiring Heparin Free Dialysis Treatments) Phase 3 (Venous Thromboembolism) Phase 3 (Chronic Renal Failure) (Off Pump Coronary Artery Bypass Surgery) (Catheter-Related Infections) (Second Degree Burns) (Coronary Artery Disease) Phase 4 (Venous Thromboembolic Disease|Deep Vein Thrombosis|Pulmonary Embolism) Phase 3 (Cardiovascular Disease|Coronary Artery Bypass Surgery) Phase 3 (Inhalation Injury|Burn Injury) Phase 1 (Heparin-Induced Thrombocytopenia) Phase 4 (Pregnancy|Miscarriage) (Brain Tumor|Spinal Stenosis|Cerebral Artery Anuerysm) (Septic Shock) Phase 4 (Acute Kidney Injury|Hemodialysis) Phase 3 (Peripheral Venous Catheter Complications|Occlusion|Phlebitis|Ecchymosis) (Peripheral Vascular Diseases) Phase 2 (Haemodialysis) Phase 4 (Cardiac Surgery|Cardiopulmonary Bypass|Obese Patients (BMI ≥ 30 kg/m²)) Phase 3 (Embolism) Phase 1 (Oral Mucositis) Phase 1 (Healthy Volunteers) Phase 4 (Acquired Platelet Function Disorder) Phase 4 (Heart Disease, Ischemic) (Deep Venous Thrombosis) Phase 1|Phase 2 (Thromboprophylaxis|Thoracic Surgery) (Peripheral Revascularisation) Phase 2 (Sepsis) (Liver Cirrhosis|Portal Hypertension) Phase 2 (Acute Chest Syndrome|Sickle Cell Disease) Phase 4 (Sepsis) Phase 4 (Cardiac Surgery|Cardiopulmonary Bypass|Anticoagulation) Phase 4 (Heparin-Induced Thrombocytopenia) Phase 4 (Acute Myocardial Infarction|Percutaneous Coronary Intervention) (Adult Chronic Haemodialysis Patients Since at Least 3 Months) Phase 1|Phase 2 (Recurrent Urinary Tract Infections) Phase 3 (Sepsis|Bacterial Infections) Phase 2 (Recurrent Abortion) (Cicatrix) Phase 1 (Healthy) (Anaphylaxis) Phase 4 (Respiration, Artificial|Hemorrhage) (Lymphoma|Thromboembolism|Unspecified Adult Solid Tumor, Protocol Specific) Phase 3 (Acute Coronary Syndromes) Phase 3 (Thromboembolism) Phase 4 (Pulmonary Embolism|Thromboembolism|Vascular Diseases|Thrombosis) Phase 4 (Heparin|Heparin Overdose|Bleeding) Phase 2 (Acute Coronary Syndrome (ACS)) Phase 2|Phase 3 (Infertility) (Intra Operative Bleeding, Blood Salvage) (Inflammatory Reaction) Phase 4 (LOVASTATIN/TICAGRELOR [VA Drug Interaction]) Phase 2 (Coronary Artery Disease) Phase 3 (Cardiac Arrhythmias|Hemorrhage|Thromboembolism) Phase 4 (Myocardial Infarction) Phase 4 (Acute Kidney Failure) Phase 4 (End-stage Renal Disease) Phase 2 (Septic Shock) (Recurrent Pregnancy Loss|Antiphospholipid Antibody Syndrome) Phase 3 (Angioplasty, Transluminal, Percutaneous Coronary) Phase 3 (Acute Myocardial Infarction) (Infertility|Fertilization in Vitro|Recurrent Implantation Failure) Phase 3 (Cardiac Surgery|Coronary Artery Bypass Surgery) Phase 4 (Patients With Acute Renal Insufficiency) Phase 3 (Rhegmatogenous Retinal Detachment|High-risk for Proliferative Vitreoretinopathy (PVR)) (Urolithiasis|Renal Hematoma) Phase 4 (Deep Vein Thrombosis|Cancer) Phase 4 (Infection of Intravenous Catheter|Phlebitis|Extravasation of Diagnostic and Therapeutic Materials) Phase 4 (Angina, Unstable|Myocardial Infarction) Phase 3 (Venous Thromboembolism|Deep Vein Thrombosis (DVT)|Pulmonary Embolism (PE)|Thromboembolism|Venous Thrombosis) Phase 4 (Venous Thromboembolism) Phase 2|Phase 3 (Foot Ulcer, Diabetic|Diabetic Angiopathies) Phase 2 (Deep Vein Thrombosis|Venous Thrombosis) Phase 2|Phase 3 (Venous Thromboembolism) Phase 4 (Infertility) Phase 4 (Renal Dialysis|Catheter-Related Infections) Phase 3 (Bacteremia|Neoplasms) Phase 4 (Mesenteric Ischemia) (Renal Failure|Hemodialysis) Phase 4 (Deep Vein Thrombosis) Phase 3 (Deep Venous Thrombosis) Phase 4 (Endstage Renal Disease) (Cardiovascular Diseases) Phase 4 (Kidney Failure, Chronic) Early Phase 1 (Antiphospholipid Syndrome in Pregnancy|Pregnancy Loss) Phase 3 (Myocardial Infarction) Phase 3 (Malignant Female Reproductive System Neoplasm) (Obesity|Insulin Resistance) Phase 4 (Coronary Disease|Angina Pectoris) Phase 3 (Kidney Failure, Chronic|Catheter-Related Infections) Phase 4 (Myocardial Infarction|Coronary Disease) Phase 4 (This Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment.) Phase 3 (Percutaneous Coronary Intervention) (Type 1 Diabetes Mellitus) Phase 4 (Acute Coronary Syndrome) Phase 4 (Acute Renal Insufficiency) Phase 3 (Severe Aortic Stenosis|Transcatheter Aortic Valve Replacement|Aortic Valve Replacement) Phase 3 (Peripheral Endovascular Interventions|Bleeding) Phase 2 (Metastatic Pancreatic Cancer) (Angioedema) (Other Fatty Acid Oxidation Disorders|Diabetes Mellitus|Insulin Resistance) Phase 3 (Dialysis Catheter Infections) (Acute Pancreatitis) Phase 4 (Acute ST Elevation Myocardial Infarction) Phase 3 (Catheter-Related Infections) (Post Polypectomy Bleeding in Anticoagulated Patients|Gastrointestinal Hemorrhage) (Catheter Related Infection|Bacteremia) Phase 3 (Proliferative Vitreoretinopathy) Phase 2 (Cataract|Uveitis) Phase 3 (Infection) Phase 4 (Acute Kidney Injury) Phase 3 (Submassive Pulmonary Embolism) Phase 3 (Hematological Malignancies|Bacteremia|Thrombosis) (Cardiac Surgery) Phase 4 (Prostate Cancer|Venous Thromboembolism|Lymphocele After Surgical Procedure|Deep Venous Thrombosis|Pulmonary Embolism) Phase 4 (Diabetes Mellitus|Hemodialysis) Phase 2 (Pelvic Pain|Interstitial Cystitis|Bladder Diseases) Phase 4 (Bruises) (Recurrent Pregnancy Losses|Positive Anti Phospholipid Syndrome) Phase 4 (Hematoma) (End Stage Renal Disease) Phase 3 (Critical Illness|Deep Venous Thrombosis) Phase 2 (Angioplasty, Transluminal, Percutaneous Coronary) Phase 2 (Coronary Disease) Phase 2 (Pneumonia) Phase 3 (Intermittent Claudication|Arterial Occlusive Diseases|Atheroslerosis) Phase 3 (Bleeding) Phase 3 (Colorectal Cancer) (Lipoprotein Lipase Deficiency) Phase 2 (Interstitial Cystitis|Bladder Pain Syndrome) Phase 3 (Childhood Cancer|Aplastic Anemia|Metabolic Disorders) Phase 1 (Cardiopulmonary Bypass|Altered Heparin Response) Phase 4 (Renal Dialysis) Phase 2|Phase 3 (Burns) Phase 3 (Heparin) (Coronary Artery Bypass Grafting) Phase 1 (Heparin) Phase 3 (Diagnostic Coronary Angiography) Phase 4 (Acute Kidney Injury|Acute Renal Failure|Heart Failure) (Left Sided Heart Failure|Left Ventricular Assist Device|Anticoagulant Therapy|Gastro Intestinal Bleeding|Thrombosis, LVAD|Anti-factor Xa|aPTT|Heparin) Phase 3 (Central Line-Associated Bloodstream Infection) Phase 3 (Infection; Dialysis Catheter) Phase 3 (Venous Thromboembolism|Neoplasms) Phase 3 (End Stage Renal Disease|Hemodialysis) Phase 2 (Cancer|Thrombosis|Venous Thromboembolism|Deep Vein Thrombosis|Pulmonary Embolus) Phase 2 (Coronary Artery Disease (CAD)|Percutaneous Coronary Intervention (PCI)) (Embolism and Thrombosis of the Radial Artery) Phase 2 (Coronary Artery Disease|Angina, Unstable) (Aneurysm) Phase 4 (Thrombophilia With Recurrent Pregnancy Loss) Phase 3 (Coronary Artery Disease) Phase 1|Phase 2 (Catheter-related Bloodstream Infection (CRBSI) Nos|Catheter-related Bloodstream Infection Due to Central Venous Catheter|Bloodstream Infection Due to Hickman Catheter) Phase 4 (Pulmonary Thromboembolisms|Pulmonary Embolism) Phase 4 (Coronary Disease) Phase 3 (Contra-Indication to the Use of Low Molecular Weight Heparin) Phase 2 (Heart Catheterization) Phase 4 (Atrial Fibrillation) Phase 3 (Bloodstream Infection) Phase 2 (Cataracts) Phase 3 (Primary PCI - STEMI) (Hemostatic Disorders) Phase 1 (Extracorporeal Membrane Oxygenation Complication) Phase 4 (Ischemic Heart Disease) Phase 2|Phase 3 (Sinus Thrombosis, Intracranial) Phase 3 (Pulmonary Embolism) (Double Lumen Infection|Hemodialysis) (Homozygous Familial Hypercholesterolemia) Phase 2 (Thrombosis) Phase 4 (Deep Vein Thrombosis|Pulmonary Embolism) (Renal Failure) Phase 3 (Cervical Artery Dissection|Carotid Artery Dissection|Vertebral Artery Dissection|Stroke) Phase 3 (Blood Clot|Trauma) Phase 4 (DVT|Osteoarthritis) Phase 3 (Cancer) (Venous Thrombosis|Neoplasms) Phase 4 (Bacteremia) Phase 4 (Chronic Kidney Disease) (Bradycardia|Tachycardia|Atrial Fibrillation|Valvular Heart Disease) Phase 3 (Acute Coronary Syndrome) (Carotid Artery Injury|Vertebral Artery Injury) Phase 4 (Pulmonary Embolism) Phase 3 (Venous Thrombosis|Cardiovascular Diseases|Venous Thromboembolism) Phase 3 (Critically Ill|Deep Venous Thrombosis) Phase 1 (Embolism|Thrombophlebitis) (Restenosis) (Pregnancy Complications) Phase 3 (Neoplasm|Venous Thromboembolism) (Liver Cirrhosis) Phase 2 (Fibrillation, Atrial) (Venous Thromboembolism|Deep Venous Thrombosis) (Bacteremia) Phase 4 (TBI (Traumatic Brain Injury)|VTE (Venous Thromboembolism)) Phase 3 (Patency|Infection) Phase 1 (End-Stage Renal Disease|Hemodialysis Catheter-Associated Infection) Phase 1 (Kidney Failure) Phase 3 (Long-term Oral Anticoagulant Therapy) Phase 3 (Renal Insufficiency) Phase 4 (Insulin Resistance Syndrome X|Pancreatic Beta Cell Function) (Unsuspected Pulmonary Embolism) Phase 2 (Myocardial Infarction|Coronary Disease) Phase 3 (Embolism, Pulmonary) Phase 3 (Thrombosis, Venous) (Hemodialysis) (Very Long-chain Acyl-CoA Dehydrogenase Deficiency|Trifunctional Protein Deficiency|Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency|Medium-chain Acyl-CoA Dehydrogenase Deficiency|Normal Volunteers) Phase 2|Phase 3 (Hemodialysis Catheter-related Bacteremia) Phase 3 (Venous Thromboembolism|Cancer) Phase 3 (Deep Vein Thrombosis) (Acute Kidney Injury) (Thrombosis, Venous) (Hyperandrogenism|Glucocorticoid Metabolism) Phase 2 (Vulvodynia) Phase 2 (Venous Thromboembolism) (Type 2 Diabetes) (Obesity|Metabolic Syndrome X) Phase 3 (Angina Pectoris|Cardiovascular Diseases|Coronary Disease|Heart Diseases|Myocardial Infarction|Myocardial Ischemia) Phase 4 (Cirrhosis|Hypertension|Status;Splenectomy|Venous Thrombosis) Phase 4 (Cirrhosis|Hypertension|Venous Thrombosis|Status; Splenectomy) Phase 2|Phase 3 (Resected Liver Metastases From Colorectal Cancer) Phase 2|Phase 3 (Preeclampsia) (Obesity|Leptin Resistance) Phase 4 (Obstruction; Catheter, Infusion Catheter (Vascular)|Catheter; Complications (Indwelling Catheter)) Phase 1|Phase 2 (Antithrombotic) (Multiple Myeloma) Phase 1 (Type1 Diabetes Mellitus) (Renal Circulation|Renal Plasma Flow|Glomerular Filtration Rate|Fatty Acids, Nonesterified) Phase 3 (Deep Vein Thrombosis|Pulmonary Embolism) Phase 2 (Diabetes Mellitus, Type I) (Acute Myocardial Infarction) Phase 4 (Coronary Artery Diseases) Phase 4 (Recurrent Pregnancy Loss) Phase 3 (Acute Kidney Injury) Phase 2 (Occlusion) (Catheter Related Infection) (Obesity|Infertility|Hypogonadotropic Hypogonadotropism|Hyperinsulinemia) Phase 3 (Retinal Artery Occlusion|Fibrinolysis|Visual Acuity|Stroke|Hemodilution)

Suppliers of Heparin

Company Name Email Tel Country
BOC Sciences [email protected] 1-631-504-6093

Fax: 1-631-614-7828Purity: Brand: BOC Sciences

Biochempartner Co., Ltd [email protected] 0086-13720134139; 0086-15971444841 China

Fax: Purity: 0.98 Brand: Biochempartner

CHEMSCENE, LLC [email protected] 732-484-9848 USA

Fax: 888-484-5008Purity: Brand:

Price and Availability: USD60/100mg () USD84/500mg ()

Carbosynth Limited [email protected] +44 (1635) 578-444

Fax: +44 (1635) 579-444Purity: Brand:

Price and Availability: USD184/100mg ()

Clearsynth Labs Limited [email protected] Worldwide Helpline No. +1-415-685-4395; US & Canada (Toll-free) : +1-800-650-8239; Europe : +44-20-3286-0885; India : +91-22-26355700 India

Fax: Purity: Brand:

Price and Availability: USD150/25mg ()

Hangzhou Peak Chemicals Co., Ltd [email protected] +86 571 88233070,88233073 CHINA

Fax: +86 571 88233092Purity: Brand:

MedChemexpress Co., Ltd. [email protected] 609-228-6898 USA

Fax: 609-228-5909Purity: Brand:

Price and Availability: USD60/100mg () USD84/500mg ()

MedKoo Biosciences, Inc. [email protected] 919-279-0682 USA

Fax: 919-980-4831Purity: Brand:

Shanghai Haoyuan Chemexpress Co., Ltd. [email protected] +86 (21) 5187-0955 / +86 (21) 5895-5995 China

Fax: +86 (21) 5895-5996Purity: Brand:

Price and Availability: USD60/100mg () USD84/500mg ()

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:
Remarks:
 

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of Heparin

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule.

Solubility of Heparin

Solubility Sources
DMSO MedChemexpress Co., Ltd.

Storage Condition of Heparin

Storage Condition Sources

MSDS Information

MSDS Sources

Quality Control and Spectral Data

QC Reports Sources

Mechanism and Indications

Signaling Pathways Autophagy
Target Autophagy
Research Area Others
Indications Stable Angina|Angina, Unstable|Non-ST Elevation (NSTEMI) Myocardial Infarction Obesity|Morbid Obesity|Venous Thromboembolism|Atrial Fibrillation|Angina|Chest Pain Recurrent Pregnancy Loss Postoperative Hemorrhage Venous Thromboembolism Renal Failure Arteriovenous Fistula Aortic Stenosis, Non-rheumatic Chronic Renal Failure Sepsis|Disseminated Intravascular Coagulation Cardiac Surgery Aneurysmal Subarachnoid Hemorrhage|Neurobehavioral Manifestations|Vasospasm, Intracranial|Intracranial Aneurysm|Heparin-induced Thrombocytopenia Type II Renal Failure Chronic Requiring Hemodialysis Prevention of Venous Thromboembolism Cardiogenic Shock Coagulation; Intravascular Coronary Angiography Thrombosis Catheter-Related Infections ST-segment Elevation Myocardial Infarction|Non ST-segment Elevation Myocardial Infarction Coronary Angiograph Deep Venous Thrombosis Coronary Artery Disease Pregnancy|Thrombophilia To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come Infant, Premature|Anticoagulants|Thrombosis Thrombus Cancer Catheter Related Infection Embolic Stroke Deep-Venous Thrombosis|Pulmonary Embolism|Venous Thromboembolism Lower Extremity Deep Venous Thrombosis Severe Sepsis With Septic Shock|Severe Sepsis Without Septic Shock Hip Fracture Surgery End Stage Renal Disease Acute Ischemic Stroke Cardiac Surgery|Extracorporeal Circulation Venous Thrombosis End Stage Renal Failure on Dialysis Catheter-related Bloodstream Infection (CRBSI) Nos Chronic Kidney Disease|Patients Requiring Heparin Free Dialysis Treatments Off Pump Coronary Artery Bypass Surgery Second Degree Burns Venous Thromboembolic Disease|Deep Vein Thrombosis|Pulmonary Embolism Cardiovascular Disease|Coronary Artery Bypass Surgery Inhalation Injury|Burn Injury Heparin-Induced Thrombocytopenia Pregnancy|Miscarriage Brain Tumor|Spinal Stenosis|Cerebral Artery Anuerysm Septic Shock Acute Kidney Injury|Hemodialysis Peripheral Venous Catheter Complications|Occlusion|Phlebitis|Ecchymosis Peripheral Vascular Diseases Haemodialysis Cardiac Surgery|Cardiopulmonary Bypass|Obese Patients (BMI ≥ 30 kg/m²) Embolism Oral Mucositis Healthy Volunteers Acquired Platelet Function Disorder Heart Disease, Ischemic Thromboprophylaxis|Thoracic Surgery Peripheral Revascularisation Sepsis Liver Cirrhosis|Portal Hypertension Acute Chest Syndrome|Sickle Cell Disease Cardiac Surgery|Cardiopulmonary Bypass|Anticoagulation Acute Myocardial Infarction|Percutaneous Coronary Intervention Adult Chronic Haemodialysis Patients Since at Least 3 Months Recurrent Urinary Tract Infections Sepsis|Bacterial Infections Recurrent Abortion Cicatrix Healthy Anaphylaxis Respiration, Artificial|Hemorrhage Lymphoma|Thromboembolism|Unspecified Adult Solid Tumor, Protocol Specific Acute Coronary Syndromes Thromboembolism Pulmonary Embolism|Thromboembolism|Vascular Diseases|Thrombosis Heparin|Heparin Overdose|Bleeding Acute Coronary Syndrome (ACS) Infertility Intra Operative Bleeding, Blood Salvage Inflammatory Reaction LOVASTATIN/TICAGRELOR [VA Drug Interaction] Cardiac Arrhythmias|Hemorrhage|Thromboembolism Myocardial Infarction Acute Kidney Failure End-stage Renal Disease Recurrent Pregnancy Loss|Antiphospholipid Antibody Syndrome Angioplasty, Transluminal, Percutaneous Coronary Acute Myocardial Infarction Infertility|Fertilization in Vitro|Recurrent Implantation Failure Cardiac Surgery|Coronary Artery Bypass Surgery Patients With Acute Renal Insufficiency Rhegmatogenous Retinal Detachment|High-risk for Proliferative Vitreoretinopathy (PVR) Urolithiasis|Renal Hematoma Deep Vein Thrombosis|Cancer Infection of Intravenous Catheter|Phlebitis|Extravasation of Diagnostic and Therapeutic Materials Angina, Unstable|Myocardial Infarction Venous Thromboembolism|Deep Vein Thrombosis (DVT)|Pulmonary Embolism (PE)|Thromboembolism|Venous Thrombosis Foot Ulcer, Diabetic|Diabetic Angiopathies Deep Vein Thrombosis|Venous Thrombosis Renal Dialysis|Catheter-Related Infections Bacteremia|Neoplasms Mesenteric Ischemia Renal Failure|Hemodialysis Deep Vein Thrombosis Endstage Renal Disease Cardiovascular Diseases Kidney Failure, Chronic Antiphospholipid Syndrome in Pregnancy|Pregnancy Loss Malignant Female Reproductive System Neoplasm Obesity|Insulin Resistance Coronary Disease|Angina Pectoris Kidney Failure, Chronic|Catheter-Related Infections Myocardial Infarction|Coronary Disease This Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment. Percutaneous Coronary Intervention Type 1 Diabetes Mellitus Acute Coronary Syndrome Acute Renal Insufficiency Severe Aortic Stenosis|Transcatheter Aortic Valve Replacement|Aortic Valve Replacement Peripheral Endovascular Interventions|Bleeding Metastatic Pancreatic Cancer Angioedema Other Fatty Acid Oxidation Disorders|Diabetes Mellitus|Insulin Resistance Dialysis Catheter Infections Acute Pancreatitis Acute ST Elevation Myocardial Infarction Post Polypectomy Bleeding in Anticoagulated Patients|Gastrointestinal Hemorrhage Catheter Related Infection|Bacteremia Proliferative Vitreoretinopathy Cataract|Uveitis Infection Acute Kidney Injury Submassive Pulmonary Embolism Hematological Malignancies|Bacteremia|Thrombosis Prostate Cancer|Venous Thromboembolism|Lymphocele After Surgical Procedure|Deep Venous Thrombosis|Pulmonary Embolism Diabetes Mellitus|Hemodialysis Pelvic Pain|Interstitial Cystitis|Bladder Diseases Bruises Recurrent Pregnancy Losses|Positive Anti Phospholipid Syndrome Hematoma Critical Illness|Deep Venous Thrombosis Coronary Disease Pneumonia Intermittent Claudication|Arterial Occlusive Diseases|Atheroslerosis Bleeding Colorectal Cancer Lipoprotein Lipase Deficiency Interstitial Cystitis|Bladder Pain Syndrome Childhood Cancer|Aplastic Anemia|Metabolic Disorders Cardiopulmonary Bypass|Altered Heparin Response Renal Dialysis Burns Heparin Coronary Artery Bypass Grafting Diagnostic Coronary Angiography Acute Kidney Injury|Acute Renal Failure|Heart Failure Left Sided Heart Failure|Left Ventricular Assist Device|Anticoagulant Therapy|Gastro Intestinal Bleeding|Thrombosis, LVAD|Anti-factor Xa|aPTT|Heparin Central Line-Associated Bloodstream Infection Infection; Dialysis Catheter Venous Thromboembolism|Neoplasms End Stage Renal Disease|Hemodialysis Cancer|Thrombosis|Venous Thromboembolism|Deep Vein Thrombosis|Pulmonary Embolus Coronary Artery Disease (CAD)|Percutaneous Coronary Intervention (PCI) Embolism and Thrombosis of the Radial Artery Coronary Artery Disease|Angina, Unstable Aneurysm Thrombophilia With Recurrent Pregnancy Loss Catheter-related Bloodstream Infection (CRBSI) Nos|Catheter-related Bloodstream Infection Due to Central Venous Catheter|Bloodstream Infection Due to Hickman Catheter Pulmonary Thromboembolisms|Pulmonary Embolism Contra-Indication to the Use of Low Molecular Weight Heparin Heart Catheterization Atrial Fibrillation Bloodstream Infection Cataracts Primary PCI - STEMI Hemostatic Disorders Extracorporeal Membrane Oxygenation Complication Ischemic Heart Disease Sinus Thrombosis, Intracranial Pulmonary Embolism Double Lumen Infection|Hemodialysis Homozygous Familial Hypercholesterolemia Deep Vein Thrombosis|Pulmonary Embolism Cervical Artery Dissection|Carotid Artery Dissection|Vertebral Artery Dissection|Stroke Blood Clot|Trauma DVT|Osteoarthritis Venous Thrombosis|Neoplasms Bacteremia Chronic Kidney Disease Bradycardia|Tachycardia|Atrial Fibrillation|Valvular Heart Disease Carotid Artery Injury|Vertebral Artery Injury Venous Thrombosis|Cardiovascular Diseases|Venous Thromboembolism Critically Ill|Deep Venous Thrombosis Embolism|Thrombophlebitis Restenosis Pregnancy Complications Neoplasm|Venous Thromboembolism Liver Cirrhosis Fibrillation, Atrial Venous Thromboembolism|Deep Venous Thrombosis TBI (Traumatic Brain Injury)|VTE (Venous Thromboembolism) Patency|Infection End-Stage Renal Disease|Hemodialysis Catheter-Associated Infection Kidney Failure Long-term Oral Anticoagulant Therapy Renal Insufficiency Insulin Resistance Syndrome X|Pancreatic Beta Cell Function Unsuspected Pulmonary Embolism Embolism, Pulmonary Thrombosis, Venous Hemodialysis Very Long-chain Acyl-CoA Dehydrogenase Deficiency|Trifunctional Protein Deficiency|Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency|Medium-chain Acyl-CoA Dehydrogenase Deficiency|Normal Volunteers Hemodialysis Catheter-related Bacteremia Venous Thromboembolism|Cancer Hyperandrogenism|Glucocorticoid Metabolism Vulvodynia Type 2 Diabetes Obesity|Metabolic Syndrome X Angina Pectoris|Cardiovascular Diseases|Coronary Disease|Heart Diseases|Myocardial Infarction|Myocardial Ischemia Cirrhosis|Hypertension|Status;Splenectomy|Venous Thrombosis Cirrhosis|Hypertension|Venous Thrombosis|Status; Splenectomy Resected Liver Metastases From Colorectal Cancer Preeclampsia Obesity|Leptin Resistance Obstruction; Catheter, Infusion Catheter (Vascular)|Catheter; Complications (Indwelling Catheter) Antithrombotic Multiple Myeloma Type1 Diabetes Mellitus Renal Circulation|Renal Plasma Flow|Glomerular Filtration Rate|Fatty Acids, Nonesterified Diabetes Mellitus, Type I Coronary Artery Diseases Occlusion Obesity|Infertility|Hypogonadotropic Hypogonadotropism|Hyperinsulinemia Retinal Artery Occlusion|Fibrinolysis|Visual Acuity|Stroke|Hemodilution

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Heparin San Filippo Neri General Hospital|University of Roma La Sapienza Stable Angina|Angina, Unstable|Non-ST Elevation (NSTEMI) Myocardial Infarction 2010/1/01 Phase 4
Heparin Nazareth Hospital Obesity|Morbid Obesity|Venous Thromboembolism|Atrial Fibrillation|Angina|Chest Pain 2011/7/01
Heparin Benha University Recurrent Pregnancy Loss 2012/6/01 Phase 3
Heparin Mayo Clinic|Medtronic Postoperative Hemorrhage 2001/6/01 Phase 3
Heparin New York University School of Medicine Venous Thromboembolism 2016/3/01
Heparin Oslo University Hospital Renal Failure 2011/9/01 Phase 4
Heparin Fatemeh Hoseinzadegan|Shahid Beheshti University of Medical Sciences Arteriovenous Fistula 2011/1/01 Phase 4
Heparin University Hospital, Montpellier Aortic Stenosis, Non-rheumatic 2013/1/01 Phase 4
Heparin Azidus Brasil Chronic Renal Failure 2007/9/01 Phase 2|Phase 3
Heparin Sepsis|Disseminated Intravascular Coagulation 2016/5/01 Phase 3
Heparin Azidus Brasil Cardiac Surgery 2009/6/01 Phase 3
Heparin Robert F James, MD, FACS, FAANS|University of Louisville Aneurysmal Subarachnoid Hemorrhage|Neurobehavioral Manifestations|Vasospasm, Intracranial|Intracranial Aneurysm|Heparin-induced Thrombocytopenia Type II 2016/3/01 Phase 2
Heparin Azidus Brasil Cardiac Surgery 2009/6/01 Phase 3
Heparin Baxter Healthcare Corporation|University of Louisville|Gambro Renal Products, Inc. Renal Failure Chronic Requiring Hemodialysis 2011/3/01
Heparin Azidus Brasil Cardiac Surgery 2009/6/01 Phase 3
Heparin Azidus Brasil Prevention of Venous Thromboembolism 2010/4/01 Phase 3
Heparin Azidus Brasil Cardiac Surgery 2009/7/01 Phase 3
Heparin William Beaumont Hospitals Cardiogenic Shock 2006/1/01 Phase 2
Heparin Yong Seog Oh|Seoul St. Mary's Hospital Coagulation; Intravascular 2012/12/01 Phase 3
Heparin University of Patras Coronary Angiography 2015/2/01 Phase 4
Heparin Stanford University Thrombosis 2005/11/01
Heparin Hospital de Clinicas de Porto Alegre Catheter-Related Infections 2014/9/01 Phase 4
Heparin Uppsala University|Lund University ST-segment Elevation Myocardial Infarction|Non ST-segment Elevation Myocardial Infarction 2014/6/01 Phase 4
Heparin University of Alberta Coronary Angiograph 2008/7/01 Phase 4
Heparin Washington University School of Medicine|Barnes-Jewish Hospital|Canyon Pharmaceuticals, Inc. Deep Venous Thrombosis 2006/5/01 Phase 2|Phase 3
Heparin Azidus Brasil Cardiac Surgery 2009/6/01 Phase 3
Heparin Deutsches Herzzentrum Muenchen Coronary Artery Disease 2008/8/01 Phase 4
Heparin Yazd Medical University|Yazd Research & Clinical Center for Infertility Pregnancy|Thrombophilia 2009/5/01 Phase 4
Heparin Dr.Vandana Bansal|Jeevan Jyoti Hospital To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come 2013/8/01 Phase 3
Heparin The University of Texas Health Science Center at San Antonio Infant, Premature|Anticoagulants|Thrombosis 2010/1/01
Heparin Azidus Brasil Thrombus 2010/4/01 Phase 3
Heparin Azidus Brasil Prevention of Venous Thromboembolism 2010/4/01 Phase 3
Heparin M.D. Anderson Cancer Center|National Cancer Institute (NCI) Cancer
Heparin McMaster University Coronary Artery Disease 2011/6/01 Phase 4
Heparin Catholic University of Pelotas Catheter Related Infection 2012/7/01 Phase 4
Heparin Shiraz University of Medical Sciences Embolic Stroke 2014/1/01 Phase 2
Heparin University of Utah Deep-Venous Thrombosis|Pulmonary Embolism|Venous Thromboembolism 2016/11/01 Early Phase 1
Heparin Lisa Louwers|William Beaumont Hospitals Lower Extremity Deep Venous Thrombosis 2011/3/01
Heparin Indonesia University Severe Sepsis With Septic Shock|Severe Sepsis Without Septic Shock 2013/1/01 Phase 3
Heparin Eurofarma Laboratorios S.A. Hip Fracture Surgery 2011/10/01 Phase 3
Heparin Ash Access Technology End Stage Renal Disease 2006/7/01 Phase 3
Heparin University Hospital, Martin Acute Ischemic Stroke 2013/5/01 Phase 4
Heparin University Hospital, Bordeaux Cardiac Surgery|Extracorporeal Circulation 2008/6/01 Phase 4
Heparin University Of Perugia 2010/9/01 Phase 3
Heparin University of Colorado, Denver Venous Thrombosis 2007/5/01
Heparin Tehran University of Medical Sciences End Stage Renal Failure on Dialysis 2011/3/01
Heparin Palle Bekker Jeppesen|TauroPharm|Rigshospitalet, Denmark Catheter-related Bloodstream Infection (CRBSI) Nos 2013/10/01 Phase 4
Heparin Baxter Healthcare Corporation|Statistical Analysis : CIC CHU Brabois Nancy|Gambro Lundia AB Chronic Kidney Disease|Patients Requiring Heparin Free Dialysis Treatments 2011/3/01
Heparin Azidus Brasil Venous Thromboembolism 2010/5/01 Phase 3
Heparin Laboratório Químico Farmacêutico Bergamo Ltda.|Azidus Brasil Chronic Renal Failure 2011/10/01 Phase 3
Heparin Yonsei University Off Pump Coronary Artery Bypass Surgery 2007/4/01
Heparin Hospital General Universitario Gregorio Marañon|Instituto de Salud Carlos III|Fundación para la Investigación Biomédica del Hospital Gregorio Maranon Catheter-Related Infections 2015/10/01
Heparin King Edward Medical University Second Degree Burns 2015/4/01
Heparin Olivier F. Bertrand|Community Medical Center, Scranton, PA|Sheth Vadilal Sarabhai General Hospital|Laval University Coronary Artery Disease 2009/5/01
Heparin Scripps Health Venous Thromboembolic Disease|Deep Vein Thrombosis|Pulmonary Embolism 2012/11/01 Phase 4
Heparin The Medicines Company Cardiovascular Disease|Coronary Artery Bypass Surgery 2004/4/01 Phase 3
Heparin Duke University Thrombosis 2006/6/01
Heparin Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Dutch Burns Foundation Inhalation Injury|Burn Injury 2013/10/01 Phase 3
Heparin McMaster University|Heart and Stroke Foundation of Ontario Heparin-Induced Thrombocytopenia 2007/12/01 Phase 1
Heparin University of Khartoum Pregnancy|Miscarriage 2009/1/01 Phase 4
Heparin Seoul National University Bundang Hospital Brain Tumor|Spinal Stenosis|Cerebral Artery Anuerysm 2012/1/01
Heparin Hospices Civils de Lyon Septic Shock 2013/5/01
Heparin University Hospital, Antwerp Acute Kidney Injury|Hemodialysis 2011/1/01 Phase 4
Heparin IRCCS Policlinico S. Matteo Peripheral Venous Catheter Complications|Occlusion|Phlebitis|Ecchymosis 2007/6/01 Phase 3
Heparin University Hospital, Ghent|JOTEC Company Peripheral Vascular Diseases 2004/4/01
Heparin Cyathus Exquirere Pharmaforschungsgmbh Haemodialysis 2011/7/01 Phase 2
Heparin University Hospital, Strasbourg, France Cardiac Surgery|Cardiopulmonary Bypass|Obese Patients (BMI ≥ 30 kg/m²) 2015/12/01 Phase 4
Heparin Novartis Pharmaceuticals|Novartis Embolism 2006/2/01 Phase 3
Heparin Swedish Orphan Biovitrum Oral Mucositis 2010/7/01 Phase 1
Heparin Swedish Orphan Biovitrum Healthy Volunteers 2005/12/01 Phase 1
Heparin Hôpital Necker-Enfants Malades|Bambino Gesù Hospital and Research Institute Acquired Platelet Function Disorder 2012/9/01 Phase 4
Heparin University Hospital of Ferrara Heart Disease, Ischemic 2015/5/01 Phase 4
Heparin W.L.Gore & Associates Peripheral Vascular Diseases 2007/10/01
Heparin University of Tennessee Deep Venous Thrombosis 2010/2/01
Heparin West China Hospital Thromboprophylaxis|Thoracic Surgery 2016/6/01 Phase 1|Phase 2
Heparin Centre hospitalier de l'Université de Montréal (CHUM) Peripheral Revascularisation 2015/9/01
Heparin University of Colorado, Denver Sepsis 2010/12/01 Phase 2
Heparin Centre hospitalier de l'Université de Montréal (CHUM) Thrombosis 2010/4/01
Heparin West China Hospital Liver Cirrhosis|Portal Hypertension 2017/6/01
Heparin University of Pittsburgh|Vascular Medicine Institute Acute Chest Syndrome|Sickle Cell Disease 2014/5/01 Phase 2
Heparin Eli Lilly and Company Sepsis 2002/12/01 Phase 4
Heparin Triemli Hospital Coronary Artery Disease 2003/9/01 Phase 4
Heparin SANE-Society of Anesthesiology|Instituto de Cardiologia do Rio Grande do Sul|Fundação Universitária de Cardiologia (University Foundation of Cardiology) Cardiac Surgery|Cardiopulmonary Bypass|Anticoagulation 2009/7/01 Phase 4
Heparin University Medicine Greifswald|Novartis Heparin-Induced Thrombocytopenia 2003/1/01 Phase 4
Heparin Shenyang Northern Hospital Acute Myocardial Infarction|Percutaneous Coronary Intervention 2012/8/01 Phase 4
Heparin Centre Hospitalier Universitaire de Nice Adult Chronic Haemodialysis Patients Since at Least 3 Months 2010/10/01
Heparin Oregon Health and Science University Recurrent Urinary Tract Infections 2014/11/01 Phase 1|Phase 2
Heparin Universidad de Antioquia|Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) Sepsis|Bacterial Infections 2005/7/01 Phase 3
Heparin Cairo University|Ahmed Elgazzar Hospital Recurrent Abortion 2006/6/01 Phase 2
Heparin Suleymaniye Birth And Women's Health Education And Research Hospital Cicatrix 2015/12/01
Heparin Azidus Brasil Healthy 2013/2/01 Phase 1
Heparin University of Missouri, Kansas City|Truman Medical Center|Saint Luke's Hospital|Emergency Physicians Foundation of KC|American College of Emergency Physicians Anaphylaxis 2009/12/01
Heparin University Medicine Greifswald Respiration, Artificial|Hemorrhage 2003/12/01 Phase 4
Heparin Azidus Brasil Healthy 2013/2/01 Phase 1
Heparin Northwestern University|National Cancer Institute (NCI) Lymphoma|Thromboembolism|Unspecified Adult Solid Tumor, Protocol Specific 1996/7/01
Heparin Medstar Health Research Institute|GlaxoSmithKline Acute Coronary Syndromes 2007/6/01 Phase 3
Heparin Novartis Thromboembolism 2007/1/01 Phase 3
Heparin Beijing Chao Yang Hospital Pulmonary Embolism|Thromboembolism|Vascular Diseases|Thrombosis 2002/6/01 Phase 4
Heparin Adiyaman University Research Hospital Heparin|Heparin Overdose|Bleeding 2017/4/30 Phase 4
Heparin Regado Biosciences, Inc. Acute Coronary Syndrome (ACS) 2009/7/01 Phase 2
Heparin National and Kapodistrian University of Athens Infertility 2012/1/01 Phase 2|Phase 3
Heparin Centre hospitalier de l'Université de Montréal (CHUM) Thrombosis 2013/9/01
Heparin Ziekenhuis Oost-Limburg Intra Operative Bleeding, Blood Salvage 2016/2/01
Heparin Wenzhou Medical University Inflammatory Reaction 2013/11/01
Heparin Beijing Anzhen Hospital LOVASTATIN/TICAGRELOR [VA Drug Interaction] 2015/4/01 Phase 4
Heparin Regado Biosciences, Inc. Coronary Artery Disease 2007/10/01 Phase 2
Heparin McMaster University Cardiac Arrhythmias|Hemorrhage|Thromboembolism 2007/12/01 Phase 3
Heparin Deutsches Herzzentrum Muenchen Myocardial Infarction 2009/9/01 Phase 4
Heparin Catholic University of the Sacred Heart Acute Kidney Failure 2007/9/01 Phase 4
Heparin The University of Texas Health Science Center, Houston|University Hospitals Cleveland Medical Center|University of Arkansas|Ochsner Health System End-stage Renal Disease 2012/11/01 Phase 4
Heparin University of Manitoba Septic Shock 2012/7/01 Phase 2
Heparin Mount Sinai Hospital, Canada|Canadian Institutes of Health Research (CIHR)|Pfizer Recurrent Pregnancy Loss|Antiphospholipid Antibody Syndrome 2000/3/01
Heparin Centocor, Inc. Angioplasty, Transluminal, Percutaneous Coronary 1995/2/01 Phase 3
Heparin Robert Welsh|Sanofi|Boehringer Ingelheim|University of Alberta Acute Myocardial Infarction 2008/10/01 Phase 3
Heparin V.K.V. American Hospital, Istanbul Infertility|Fertilization in Vitro|Recurrent Implantation Failure 2006/1/01
Heparin The Medicines Company Cardiac Surgery|Coronary Artery Bypass Surgery 2003/8/01 Phase 3
Heparin Centre Hospitalier Universitaire Dijon Patients With Acute Renal Insufficiency 2013/6/01 Phase 4
Heparin Stony Brook University Coronary Artery Disease 2009/7/01 Phase 4
Heparin Universitätsklinikum Köln|German Research Foundation|The Clinical Trials Centre Cologne|Pharmacy of the University Hospital Erlangen|Institute of Medical Statistics, Informatics and Epidemiology (IMSIE) Rhegmatogenous Retinal Detachment|High-risk for Proliferative Vitreoretinopathy (PVR) 2016/10/01 Phase 3
Heparin Kantonsspital Winterthur KSW Urolithiasis|Renal Hematoma 2009/1/01
Heparin Azienda Ospedaliera Universitaria Policlinico Deep Vein Thrombosis|Cancer 2005/3/01 Phase 4
Heparin University of Florence Infection of Intravenous Catheter|Phlebitis|Extravasation of Diagnostic and Therapeutic Materials 2013/1/01 Phase 4
Heparin Pfizer Angina, Unstable|Myocardial Infarction 2007/6/01 Phase 4
Heparin Daiichi Sankyo Inc. Venous Thromboembolism|Deep Vein Thrombosis (DVT)|Pulmonary Embolism (PE)|Thromboembolism|Venous Thrombosis 2009/10/01 Phase 3
Heparin Pfizer Venous Thromboembolism 2007/6/01 Phase 4
Heparin Spanish National Health System|Carlos III Health Institute|Rovi Pharmaceuticals Laboratories Foot Ulcer, Diabetic|Diabetic Angiopathies 2001/6/01 Phase 2|Phase 3
Heparin Daiichi Sankyo Inc. Deep Vein Thrombosis|Venous Thrombosis 2012/8/01 Phase 2
Heparin National and Kapodistrian University of Athens Infertility 2010/11/01 Phase 2|Phase 3
Heparin Azidus Brasil Venous Thromboembolism 2010/5/01 Phase 2|Phase 3
Heparin Nanfang Hospital of Southern Medical University Infertility 2016/7/01 Phase 4
Heparin Imperial College Healthcare NHS Trust Renal Dialysis|Catheter-Related Infections 2010/8/01 Phase 4
Heparin Aarhus University Hospital|Danish Child Cancer Foundation|TauroPharm Bacteremia|Neoplasms 2008/4/01 Phase 3
Heparin Mansoura University Mesenteric Ischemia 2015/10/01 Phase 4
Heparin St. Orsola Hospital Renal Failure|Hemodialysis 2008/3/01
Heparin LEO Pharma Deep Vein Thrombosis 2005/12/01 Phase 4
Heparin Aalborg Universitetshospital|Aalborg University Deep Venous Thrombosis 1993/10/01 Phase 3
Heparin Alice Ho Miu Ling Nethersole Hospital Endstage Renal Disease 2016/3/01 Phase 4
Heparin Rijnstate Hospital Cardiovascular Diseases 2010/10/01
Heparin Christine Ribic|McMaster University|LEO Pharma|St. Joseph's Healthcare Hamilton Kidney Failure, Chronic 2013/9/01 Phase 4
Heparin Shenzhen Salubris Pharmaceuticals Co., Ltd. Acute Myocardial Infarction 2016/11/01 Phase 3
Heparin Ottawa Hospital Research Institute Antiphospholipid Syndrome in Pregnancy|Pregnancy Loss 2017/4/01 Early Phase 1
Heparin Cordis Corporation Coronary Artery Disease 2003/10/01 Phase 2
Heparin Boehringer Ingelheim Myocardial Infarction 2000/7/01 Phase 3
Heparin National Guard Health Affairs Malignant Female Reproductive System Neoplasm 2009/10/01 Phase 3
Heparin University of California, Davis|Dialysis Clinic, Inc. Obesity|Insulin Resistance 2008/10/01
Heparin Deutsches Herzzentrum Muenchen Coronary Disease|Angina Pectoris 2005/11/01 Phase 4
Heparin CorMedix|PPD|JMI Laboratories|Spectra Clinical Research|Davita Clinical Research|Frenova Renal Research Kidney Failure, Chronic|Catheter-Related Infections 2015/12/01 Phase 3
Heparin Deutsches Herzzentrum Muenchen Myocardial Infarction|Coronary Disease 2006/7/01 Phase 4
Heparin Cedars-Sinai Medical Center Venous Thromboembolism 2013/9/01 Phase 3
Heparin Careggi Hospital Coronary Artery Disease 2007/3/01 Phase 4
Heparin Ataturk University This Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment. 2011/1/01 Phase 4
Heparin Kaiser Permanente Percutaneous Coronary Intervention 2015/5/01 Phase 3
Heparin Corline Biomedical AB Type 1 Diabetes Mellitus 2016/4/01
Heparin GlaxoSmithKline Acute Coronary Syndrome 2009/2/01 Phase 4
Heparin Centre Hospitalier Universitaire Dijon Acute Renal Insufficiency 2015/2/01 Phase 4
Heparin The Medicines Company Severe Aortic Stenosis|Transcatheter Aortic Valve Replacement|Aortic Valve Replacement 2012/10/01 Phase 3
Heparin Boehringer Ingelheim Myocardial Infarction 2000/5/01 Phase 3
Heparin The Medicines Company Peripheral Endovascular Interventions|Bleeding 2013/9/24 Phase 3
Heparin Cantex Pharmaceuticals|Translational Drug Development Metastatic Pancreatic Cancer 2011/11/01 Phase 2
Heparin University of Iowa|FDA Office of Orphan Products Development Angioedema 1994/1/01
Heparin Temple University Other Fatty Acid Oxidation Disorders|Diabetes Mellitus|Insulin Resistance 2003/6/01
Heparin Great Lakes Pharmaceuticals Inc. Dialysis Catheter Infections 2012/7/01 Phase 3
Heparin Nanjing University School of Medicine Acute Pancreatitis 2011/9/01
Heparin Liverpool Heart and Chest Hospital NHS Foundation Trust Acute ST Elevation Myocardial Infarction 2012/2/01 Phase 4
Heparin Institute of Child Health Catheter-Related Infections 2010/1/01 Phase 3
Heparin Hadassah Medical Organization|Rambam Health Care Campus|Carmel Medical Center|Soroka University Medical Center|Tel Aviv Medical Center Post Polypectomy Bleeding in Anticoagulated Patients|Gastrointestinal Hemorrhage 2015/5/01
Heparin Third Military Medical University|Chongqing Medical University Thrombosis 2009/1/01
Heparin University of Manitoba|MED XL Inc|Winnipeg Regional Health Authority Catheter Related Infection|Bacteremia 2011/8/01
Heparin Shahid Beheshti University of Medical Sciences Proliferative Vitreoretinopathy 2005/2/01 Phase 3
Heparin National Eye Institute (NEI) Cataract|Uveitis 1994/3/01 Phase 2
Heparin Centre National de Greffe de Moelle Osseuse Infection 2005/5/01 Phase 3
Heparin University Hospital Muenster|University of Leipzig|German Research Foundation Acute Kidney Injury 2016/3/01 Phase 4
Heparin EKOS Corporation Submassive Pulmonary Embolism 2010/7/01 Phase 3
Heparin Maastricht University Medical Center|Dirinco B.V. Hematological Malignancies|Bacteremia|Thrombosis 2006/7/01 Phase 3
Heparin Aalborg Universitetshospital|Medtronic Cardiac Surgery 2011/11/01
Heparin Stealth BioTherapeutics Inc. Healthy Volunteers 2012/1/01 Phase 1
Heparin Johns Hopkins University Prostate Cancer|Venous Thromboembolism|Lymphocele After Surgical Procedure|Deep Venous Thrombosis|Pulmonary Embolism 2017/7/01 Phase 4
Heparin Anemia Working Group Romania Diabetes Mellitus|Hemodialysis 2009/3/01 Phase 4
Heparin Urigen Pelvic Pain|Interstitial Cystitis|Bladder Diseases 2006/1/01 Phase 2
Heparin Hamilton Health Sciences Corporation|St. Joseph's Health Care London|McMaster University Bruises 2005/10/01 Phase 4
Heparin Woman's Health University Hospital, Egypt Recurrent Pregnancy Losses|Positive Anti Phospholipid Syndrome 2012/3/01
Heparin Ottawa Heart Institute Research Corporation|Canadian Institutes of Health Research (CIHR) Hematoma 2008/12/01 Phase 4
Heparin Cardiovascular Research Foundation, New York|Boston Scientific Corporation|The Medicines Company Myocardial Infarction 2005/3/01 Phase 3
Heparin W.L.Gore & Associates End Stage Renal Disease 2014/7/01
Heparin McMaster University|Canadian Institutes of Health Research (CIHR)|Canadian Critical Care Trials Group|Australian and New Zealand Intensive Care Society Clinical Trials Group Critical Illness|Deep Venous Thrombosis 2006/5/01 Phase 3
Heparin Sanofi Angioplasty, Transluminal, Percutaneous Coronary 2004/9/01 Phase 2
Heparin Perrault Louis P.|Montreal Heart Institute|Somahlution LLC Coronary Artery Disease 2014/9/01
Heparin Sanofi Coronary Disease 2006/6/01 Phase 2
Heparin Thrombologic ApS|Anders Perner|Rigshospitalet, Denmark Pneumonia 2012/6/01 Phase 2
Heparin Radboud University Intermittent Claudication|Arterial Occlusive Diseases|Atheroslerosis 1996/1/01 Phase 3
Heparin Clinica Mediterranea Bleeding 2008/1/01 Phase 3
Heparin NSABP Foundation Inc|National Cancer Institute (NCI)|Northern California Cancer Center Colorectal Cancer 1984/3/01 Phase 3
Heparin University of Colorado, Denver Lipoprotein Lipase Deficiency 2016/12/01
Heparin Urigen Interstitial Cystitis|Bladder Pain Syndrome 2015/9/01 Phase 2
Heparin Alberta Children's Hospital|Stollery Children's Hospital Childhood Cancer|Aplastic Anemia|Metabolic Disorders 2011/4/01 Phase 3
Heparin Shahid Beheshti University of Medical Sciences Proliferative Vitreoretinopathy 2006/9/01 Phase 3
Heparin Massachusetts General Hospital|rEVO Biologics Cardiopulmonary Bypass|Altered Heparin Response 2012/6/01 Phase 1
Heparin Randolph Quinn|Fresenius Medical Care North America Renal Dialysis 2009/12/01 Phase 4
Heparin Azidus Brasil Burns 2008/6/01 Phase 2|Phase 3
Heparin Azidus Brasil Chronic Renal Failure 2008/7/01 Phase 2|Phase 3
Heparin Tehran University of Medical Sciences Heparin 2012/2/01 Phase 3
Heparin Southlake Regional Health Centre Coronary Artery Bypass Grafting 2006/9/01
Heparin União Química Farmacêutica Nacional S/A|Buranello e Rodrigues Consultoria em Desenvolvimento Farmacêutico Ltda ME Heparin 2017/11/30 Phase 1
Heparin Prince Sultan Cardiac Center, Adult Cardiology Department. Diagnostic Coronary Angiography 2008/7/01 Phase 3
Heparin União Química Farmacêutica Nacional S/A|Buranello e Rodrigues Consultoria em Desenvolvimento Farmacêutico Ltda ME Heparin 2017/12/12 Phase 1
Heparin Azidus Brasil Cardiac Surgery 2009/7/01 Phase 3
Heparin Vanderbilt University Acute Kidney Injury|Acute Renal Failure|Heart Failure 2011/3/01 Phase 4
Heparin Washington University School of Medicine Left Sided Heart Failure|Left Ventricular Assist Device|Anticoagulant Therapy|Gastro Intestinal Bleeding|Thrombosis, LVAD|Anti-factor Xa|aPTT|Heparin 2017/5/20
Heparin St. Jude Children's Research Hospital Central Line-Associated Bloodstream Infection 2011/12/29 Phase 3
Heparin University of California, San Diego Infection; Dialysis Catheter 2012/3/01 Phase 3
Heparin University Medical Center Groningen Venous Thromboembolism|Neoplasms 2010/8/01 Phase 3
Heparin Western Galilee Hospital-Nahariya End Stage Renal Disease|Hemodialysis 2007/5/01 Phase 3
Heparin Cardiff University|National Institute for Health Research, United Kingdom|Wales Cancer Trials Unit Cancer|Thrombosis|Venous Thromboembolism|Deep Vein Thrombosis|Pulmonary Embolus 2013/3/01 Phase 2
Heparin University of Pittsburgh Catheter-Related Infections 2008/8/01
Heparin Momenta Pharmaceuticals, Inc. Coronary Artery Disease (CAD)|Percutaneous Coronary Intervention (PCI) 2007/9/01 Phase 2
Heparin Azienda Sanitaria ULSS 13 Dolo, Mirano Embolism and Thrombosis of the Radial Artery 2016/5/01
Heparin Mitsubishi Tanabe Pharma Corporation Coronary Artery Disease|Angina, Unstable 2005/8/01 Phase 2
Heparin Centre Hospitalier Universitaire, Amiens Aneurysm 2015/10/01
Heparin Stanford University Venous Thrombosis 2010/12/01
Heparin Shanghai First Maternity and Infant Hospital Thrombophilia With Recurrent Pregnancy Loss 2016/11/01 Phase 4
Heparin University of Roma La Sapienza Coronary Artery Disease 2012/4/01 Phase 3
Heparin Mayo Clinic Catheter-related Bloodstream Infection (CRBSI) Nos|Catheter-related Bloodstream Infection Due to Central Venous Catheter|Bloodstream Infection Due to Hickman Catheter 2014/7/01 Phase 1|Phase 2
Heparin Beijing Chao Yang Hospital|Ministry of Science and Technology of the People´s Republic of China Pulmonary Thromboembolisms|Pulmonary Embolism 2009/7/01 Phase 4
Heparin Laval University Coronary Artery Disease 2010/3/01 Phase 4
Heparin Chinese PLA General Hospital Coronary Disease 2016/5/01 Phase 4
Heparin Assistance Publique - Hôpitaux de Paris Contra-Indication to the Use of Low Molecular Weight Heparin 2007/5/01 Phase 3
Heparin Boehringer Ingelheim Heart Catheterization 2009/1/01 Phase 2
Heparin Pfizer|Bristol-Myers Squibb Atrial Fibrillation 2014/7/01 Phase 4
Heparin Baystate Medical Center Bloodstream Infection 2008/5/01 Phase 3
Heparin National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC) Cataracts 1992/4/01 Phase 2
Heparin Assistance Publique - Hôpitaux de Paris Primary PCI - STEMI 2008/8/01 Phase 3
Heparin The First Affiliated Hospital of Soochow University Hemostatic Disorders 2014/12/01
Heparin Policlinico Hospital Extracorporeal Membrane Oxygenation Complication 2014/9/01 Phase 1
Heparin Azienda Ospedaliera di Lecco Ischemic Heart Disease 2017/1/01 Phase 4
Heparin Jan Stam, MD, PhD|Dutch Heart Foundation|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Sinus Thrombosis, Intracranial 2011/9/01 Phase 2|Phase 3
Heparin Sanofi Pulmonary Embolism 2003/6/01 Phase 3
Heparin University Hospital, Angers Coronary Artery Bypass Grafting
Heparin Shiraz University of Medical Sciences Double Lumen Infection|Hemodialysis 2008/1/01
Heparin Laval University Homozygous Familial Hypercholesterolemia 2013/4/01
Heparin Bristol-Myers Squibb|Pediatric Heart Network|Pfizer Thrombosis 2017/1/04 Phase 2
Heparin Sunnybrook Health Sciences Centre|Canadian Institutes of Health Research (CIHR)|Pfizer Deep Vein Thrombosis|Pulmonary Embolism 2002/8/01 Phase 4
Heparin University Health Network, Toronto Renal Failure 2011/1/01
Heparin St George's, University of London|The Stroke Association, United Kingdom Cervical Artery Dissection|Carotid Artery Dissection|Vertebral Artery Dissection|Stroke 2005/11/01 Phase 3
Heparin Major Extremity Trauma Research Consortium|Patient-Centered Outcomes Research Institute Blood Clot|Trauma 2017/2/01 Phase 3
Heparin Ottawa Hospital Research Institute DVT|Osteoarthritis 2003/7/01 Phase 4
Heparin University Hospital, Limoges Cancer 1999/8/01 Phase 3
Heparin Medical College of Wisconsin|Blood Center of Wisconsin|University of Minnesota - Clinical and Translational Science Institute|Ohio State University Venous Thrombosis|Neoplasms 2014/6/01
Heparin Satellite Healthcare Bacteremia 2003/9/01 Phase 4
Heparin University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo Chronic Kidney Disease 2013/7/01 Phase 4
Heparin Johns Hopkins University Bradycardia|Tachycardia|Atrial Fibrillation|Valvular Heart Disease 2007/9/01
Heparin Xuzhou Medical University Venous Thrombosis 2014/12/01
Heparin The Medicines Company Acute Coronary Syndrome 2010/3/01 Phase 3
Heparin C. Clay Cothren, MD|Denver Health and Hospital Authority Carotid Artery Injury|Vertebral Artery Injury 2003/7/01
Heparin Azienda Ospedaliera Universitaria Policlinico Pulmonary Embolism 1999/1/01 Phase 4
Heparin National Heart, Lung, and Blood Institute (NHLBI) Venous Thrombosis|Cardiovascular Diseases|Venous Thromboembolism 1996/3/01 Phase 3
Heparin Hamilton Health Sciences Corporation|Canadian Institutes of Health Research (CIHR)|Canadian Critical Care Trials Group|McMaster University Critically Ill|Deep Venous Thrombosis 2003/2/01 Phase 3
Heparin The Catholic University of Korea Venous Thromboembolism 2011/10/01 Phase 3
Heparin National Institutes of Health Clinical Center (CC) Embolism|Thrombophlebitis 1998/2/01 Phase 1
Heparin VIVA Physicians|W.L.Gore & Associates|Spectranetics Corporation Restenosis 2007/11/01
Heparin Casa Sollievo della Sofferenza IRCCS Pregnancy Complications 2012/1/01
Heparin Azidus Brasil|Blau Farmacêutica S.A. Healthy 2013/9/01 Phase 1
Heparin Azidus Brasil Healthy 2013/3/01 Phase 1
Heparin Assistance Publique - Hôpitaux de Paris|Bayer Neoplasm|Venous Thromboembolism 2016/9/01 Phase 3
Heparin Fourth Military Medical University Liver Cirrhosis 2017/1/01
Heparin GlaxoSmithKline Fibrillation, Atrial 2009/8/01 Phase 2
Heparin University of Roma La Sapienza Venous Thromboembolism|Deep Venous Thrombosis 2015/2/01
Heparin Deutsches Herzzentrum Muenchen|Technische Universität München Myocardial Infarction 2003/6/01 Phase 4
Heparin Stanford University Catheter-Related Infections 2016/8/01
Heparin University Medical Center, Tuzla Bacteremia 2009/4/01
Heparin Loyola University TBI (Traumatic Brain Injury)|VTE (Venous Thromboembolism) 2017/4/03 Phase 4
Heparin Universitair Ziekenhuis Brussel Patency|Infection 2015/5/01 Phase 3
Heparin The Prince Charles Hospital|Sanofi|Merck Sharp & Dohme Corp. Acute Coronary Syndrome 2004/6/01 Phase 4
Heparin Baylor College of Medicine|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) End-Stage Renal Disease|Hemodialysis Catheter-Associated Infection 2006/10/01 Phase 1
Heparin University of Wisconsin, Madison|Shire Kidney Failure 2017/5/01 Phase 1
Heparin Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Long-term Oral Anticoagulant Therapy 2007/2/01 Phase 3
Heparin Centre Hospitalier Universitaire de Saint Etienne|Ministry of Health, France Renal Insufficiency 2016/11/01 Phase 3
Heparin University Health Network, Toronto Insulin Resistance Syndrome X|Pancreatic Beta Cell Function 2004/1/01 Phase 4
Heparin G. d'Annunzio University Unsuspected Pulmonary Embolism 2012/11/01
Heparin Schering-Plough Myocardial Infarction|Coronary Disease 2003/4/01 Phase 2
Heparin GlaxoSmithKline Embolism, Pulmonary 2007/7/01 Phase 3
Heparin GlaxoSmithKline Thrombosis, Venous 2008/6/01 Phase 3
Heparin American Access Care Hemodialysis 2010/10/01
Heparin Merck Sharp & Dohme Corp. Acute Coronary Syndrome 1999/11/01 Phase 3
Heparin Oregon Health and Science University Very Long-chain Acyl-CoA Dehydrogenase Deficiency|Trifunctional Protein Deficiency|Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency|Medium-chain Acyl-CoA Dehydrogenase Deficiency|Normal Volunteers 2016/2/01
Heparin University of California, San Diego|National Institutes of Health (NIH) Hemodialysis Catheter-related Bacteremia 2013/11/01 Phase 2|Phase 3
Heparin AIO-Studien-gGmbH|Charite University, Berlin, Germany|Bayer Venous Thromboembolism|Cancer 2016/3/01 Phase 3
Heparin Sanofi Deep Vein Thrombosis 2003/5/01 Phase 3
Heparin Chulalongkorn University Acute Kidney Injury 2013/7/01
Heparin GlaxoSmithKline Thrombosis, Venous 2010/1/01
Heparin Leonard-Meron Biosciences, Inc. Catheter-related Infections 2016/12/01 Phase 3
Heparin Charite University, Berlin, Germany Hyperandrogenism|Glucocorticoid Metabolism 2006/12/01
Heparin Scripps Health Vulvodynia 2012/12/01 Phase 2
Heparin GlaxoSmithKline Thrombosis, Venous 2010/2/01
Heparin Centocor, Inc. Angioplasty, Transluminal, Percutaneous Coronary 1996/7/01 Phase 3
Heparin Bayer|Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Venous Thromboembolism 2004/12/01 Phase 2
Heparin Assistance Publique Hopitaux De Marseille Type 2 Diabetes 2008/4/01
Heparin Radboud University|ZonMw: The Netherlands Organisation for Health Research and Development Obesity|Metabolic Syndrome X 2005/8/01
Heparin National Heart, Lung, and Blood Institute (NHLBI) Angina Pectoris|Cardiovascular Diseases|Coronary Disease|Heart Diseases|Myocardial Infarction|Myocardial Ischemia 1989/4/01 Phase 3
Heparin Yangzhou University Cirrhosis|Hypertension|Status;Splenectomy|Venous Thrombosis 2014/9/01 Phase 4
Heparin Yangzhou University Cirrhosis|Hypertension|Venous Thrombosis|Status; Splenectomy 2014/9/01 Phase 4
Heparin Ye Xu|Fudan University Resected Liver Metastases From Colorectal Cancer 2015/9/01 Phase 2|Phase 3
Heparin Ben-Gurion University of the Negev|Diagnostic Technologies Ltd.|Perkin Elmer Inc.|Medical University of Graz Preeclampsia 2009/8/01 Phase 2|Phase 3
Heparin Beth Israel Deaconess Medical Center Obesity|Leptin Resistance 2011/11/01
Heparin TriHealth Inc. Obstruction; Catheter, Infusion Catheter (Vascular)|Catheter; Complications (Indwelling Catheter) 2016/4/01 Phase 4
Heparin TriHealth Inc. Obstruction; Catheter, Infusion Catheter (Vascular)|Catheter; Complications (Indwelling Catheter) 2013/1/01 Phase 4
Heparin Bristol-Myers Squibb Antithrombotic 2017/4/25 Phase 1|Phase 2
Heparin University of Arkansas|National Institutes of Health (NIH)|Ortho Biotech Clinical Affairs, L.L.C. Multiple Myeloma 2001/10/01
Heparin Sanofi Type1 Diabetes Mellitus 2017/2/17 Phase 1
Heparin Medical University of Vienna Renal Circulation|Renal Plasma Flow|Glomerular Filtration Rate|Fatty Acids, Nonesterified 1999/7/01
Heparin Bayer|Janssen Research & Development, LLC Pulmonary Embolism 2012/2/01 Phase 3
Heparin Pfizer|Bristol-Myers Squibb Deep Vein Thrombosis|Pulmonary Embolism 2013/1/01 Phase 3
Heparin National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Clinical Islet Transplantation Consortium Diabetes Mellitus, Type I 2008/7/01 Phase 2
Heparin Centre Hospitalier Universitaire Vaudois|AstraZeneca Acute Myocardial Infarction 2015/9/01
Heparin Centre Hospitalier de PAU Coronary Artery Disease 2008/6/01 Phase 4
Heparin CCRF Consulting Co., Ltd. Coronary Artery Diseases 2010/5/01 Phase 4
Heparin Shanghai First Maternity and Infant Hospital Recurrent Pregnancy Loss 2014/10/01 Phase 4
Heparin Bayer|Janssen Scientific Affairs, LLC Deep Vein Thrombosis 2012/3/01 Phase 3
Heparin Seoul National University Hospital|SK Chemicals Co.,Ltd. Acute Kidney Injury 2012/3/01 Phase 3
Heparin University Hospital Ostrava|Municipal Hospital Ostrava Fifejdy|Silesian Hospital Opava Pulmonary Embolism 2011/3/01 Phase 4
Heparin National University Hospital, Singapore Occlusion 2017/7/31 Phase 2
Heparin National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diabetes Mellitus, Type I 2008/7/01 Phase 2
Heparin Hospital General Universitario Gregorio Marañon Catheter Related Infection 2009/12/01
Heparin University of Colorado, Denver Obesity|Infertility|Hypogonadotropic Hypogonadotropism|Hyperinsulinemia 2016/6/01
Heparin National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Type 1 Diabetes Mellitus
Heparin University Hospital Freiburg|Boehringer Ingelheim Retinal Artery Occlusion|Fibrinolysis|Visual Acuity|Stroke|Hemodilution 2002/9/01 Phase 3
Heparin - Launched

Chemical Information

M.Wt Formula CAS No. Synonyms
1134.93 C26H42N2O37S5 9005-49-6 6-((5-acetamido-4,6-dihydroxy-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-((5-((6-carboxy-4,5-dihydroxy-3-(sulfooxy)tetrahydro-2H-pyran-2-yl)oxy)-6-(hydroxymethyl)-3-(sulfoamino)-4-(sulfooxy)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-5-(sulfooxy)tetrahydro-2H-pyran-2-carboxylic acid

Structure Information of Heparin

Smiles OS(=O)(NC1C(OS(=O)(O)=O)C(OC2C(OS(=O)(O)=O)C(O)C(O)C(C(O)=O)O2)C(CO)OC1OC3C(O)C(OS(=O)(O)=O)C(OC4C(COS(=O)(O)=O)OC(O)C(NC(C)=O)C4O)OC3C(O)=O)=O
InChI InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)

Related Products

Other Form Products of Heparin

Name CAS Formula Suppliers
Heparin (Lithium salt) 9045-22-1 C26H42LiN2O37S5+ 3
Heparin (sodium salt) 9041-08-1 C26H42N2NaO37S5+ 10

Recommended Products in Same Target

Name CAS Formula Suppliers
Pirarubicin (Hydrochloride) 95343-20-7 C32H38ClNO12 8
Berberine (chloride) 633-65-8 C20H18ClNO4 16
DMH-1 1206711-16-1 C24H20N4O 21
CB-839 1439399-58-2 C26H24F3N7O3S 16
H-89 (dihydrochloride) 130964-39-5 C20H22BrCl2N3O2S 11
Shikonin 517-89-5 C16H16O5 22
H 89 127243-85-0 C20H20BrN3O2S 12
Eupatilin 22368-21-4 C18H16O7 13
Isoalantolactone 470-17-7 C15H20O2 13
Scutellarein 529-53-3 C15H10O6 15
Leonurine 24697-74-3 C14H21N3O5 14
Berbamine (dihydrochloride) 6078-17-7 C37H42Cl2N2O6 20
Ruxolitinib (S enantiomer) 941685-37-6 C17H18N6 14
D-Glucosamine (Hydrochloride) 66-84-2 C6H14ClNO5 32
Schizandrin A 61281-38-7 C22H28O6 8
Schisandrol B 58546-54-6 C23H28O7 8
Schisandrol A 7432-28-2 C24H32O7 7
Icaritin 118525-40-9 C21H20O6 8
Bicyclol 118159-48-1 C19H18O9 9
Azithromycin 83905-01-5 C38H72N2O12 30

Recommended Products in the Same Indication

Name CAS Formula Suppliers
Vernakalant 794466-70-9 C20H31NO4 8
Radezolid 869884-78-6 C22H23FN6O3 9
Dabigatran etexilate (mesylate) 872728-81-9 C35H45N7O8S 20
PU-H71 873436-91-0 C18H21IN6O2S 9
Quisinostat 875320-29-9 C21H26N6O2 21
AT9283 896466-04-9 C19H23N7O2 21
Exendin-4 (Acetate) 914454-01-6 C186H286N50O62S 8
Fruquintinib 1194506-26-7 C21H19N3O5 12
MLN9708 1239908-20-3 C20H23BCl2N2O9 9
Panobinostat 404950-80-7 C21H23N3O2 21
Dexamethasone 50-02-2 C22H29FO5 31
Losmapimod 585543-15-3 C22H26FN3O2 15
Colchicine 64-86-8 C22H25NO6 30
VGX-1027 6501-72-0 C11H11NO3 13
5-R-Rivaroxaban 865479-71-6 C19H18ClN3O5S 8
Carfilzomib 868540-17-4 C40H57N5O7 22
Linagliptin 668270-12-0 C25H28N8O2 23
ETC-1002 738606-46-7 C19H36O5 13
Cilostazol 73963-72-1 C20H27N5O2 30
Vernakalant (Hydrochloride) 748810-28-8 C20H32ClNO4 9

Chemical and Physical Properties

Appearance:white Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:Soluble in DMSO
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:232-681-7
Optical Rotation: alpha:

Tags: buy Heparin | Heparin IC50 | Heparin price | Heparin cost | Heparin solubility | Heparin purchase | Heparin manufacturer | Heparin research buy | Heparin order | Heparin MSDS | Heparin chemical structure | Heparin Storage condition | Heparin molecular weight | Heparin mw | Heparin datasheet | Heparin supplier | Heparin cell line | Heparin NMR | Heparin MS | Heparin IR | Heparin solubility | Heparin Safe information | Heparin Qc and Spectral Information | Heparin Clinical Information | Heparin Clinical Trial | Heparin Route of Synthesis | Heparin storage condition | Heparin diseases and conditions | Heparin flash point | Heparin boiling point | Heparin melting point | Heparin storage condition | Heparin brand